view_agenda Chapters
auto_awesome Transcript
info_circle Episode notes
Watch on YouTube
After this morning's trading update, CEO Martin Gouldstone of
Oncimmune - a leading life sciences firm providing autoantibody profiling services to the Biopharma industry – takes me through the company's current demand picture, pipeline and August FY25 guidance.
